Acid-Responsive Bimetallic Peroxide Composite Nanoplatform for Synergistic Therapy of Drug-Resistant Bacterial Infections via Inducing Oxidative Stress and Disrupting Bacterial Energy Metabolism
Bacterial infections, particularly those caused by multidrug-resistant (MDR) bacteria, pose a serious global health threat. The limited efficacy of traditional antibiotic drugs against MDR strains and the slow development of antibiotics necessitate the exploration of alternative therapeutic strategies. Acid-degradable metallic peroxide has emerged as a promising solution, exhibiting broad-spectrum antimicrobial activity with a reduced risk of resistance development. In this study, we have constructed an acid-responsive bimetallic peroxide nanocomposite (ZCS@M@HA) for the treatment of wound infections involving methicillin-resistant <i>Staphylococcus aureus</i> (MRSA). In our design, the copper-doped zinc peroxide (ZC) nanoparticles are prepared and coated with mesoporous silica to obtain core-shell structured ZC@M, which is subsequently loaded with <i>S</i>-nitroso-<i>N</i>-acetylpenicillamine (SNAP) acting as a nitric oxide (NO) donor and capped with sodium hyaluronate (HA) to prevent premature SNAP release. In the acidic microenvironment of infectious sites, ZCS@M@HA releases Zn<sup>2+</sup>, Cu<sup>2+</sup>, and H<sub>2</sub>O<sub>2</sub>, and the former disrupts bacterial energy metabolism by impairing the electron transport chain. Meanwhile, self-supplied H<sub>2</sub>O<sub>2</sub> and Cu<sup>2+</sup> perform a Fenton-like reaction to generate highly toxic hydroxyl radicals (•OH) for damaging bacterial membranes. Moreover, Cu<sup>2+</sup> depletes intracellular glutathione (GSH) to augment the oxidative stress. Furthermore, NO released from SNAP triggered by Cu<sup>2+</sup> and GSH accelerates wound healing by promoting collagen deposition, tissue regeneration, and vascularization. <i>In vivo</i> assays demonstrate the high MRSA inhibition efficacy of ZCS@M@HA with optimal wound healing. The proposed acid-responsive ZCS@M@HA with multi-bactericidal modalities offers an effective approach to fight MDR bacteria and presents a promising strategy for treating wound infections.
Authors
- Zefeng Wang (ORCID: https://orcid.org/0000-0002-4321-416X)
- Hai Luo (ORCID: https://orcid.org/0009-0001-1608-4339)
- Dinggeng He (ORCID: https://orcid.org/0000-0003-1481-6468)
- Xi Chen (ORCID: https://orcid.org/0000-0002-8911-4172)
- Weiwei Chen (ORCID: https://orcid.org/0000-0001-7681-3962)
- Yi Li (ORCID: https://orcid.org/0000-0002-4543-684X)
- Fan Yang (ORCID: https://orcid.org/0000-0003-0717-5420)
- Jie Gong (ORCID: https://orcid.org/0000-0001-5897-7023)
- Ke Yang (ORCID: https://orcid.org/0000-0001-7143-850X)
- Yawen Zheng (ORCID: https://orcid.org/0000-0001-5750-7935)
- Li Wang (ORCID: https://orcid.org/0000-0003-3722-5986)
- Weiqing Hu
Institutions
- Hunan Normal University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
- National Cancer Center (US)
- Zhejiang Institute of Freshwater Fisheries (CN)
Publication Details
- Journal
- ACS Applied Materials & Interfaces
- Published
- 2025-10-23
- DOI
- https://doi.org/10.1021/acsami.5c17878
- Citations
- 2
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 1.35